Biomolecular NMR Assignments

, Volume 10, Issue 2, pp 315–320 | Cite as

NMR backbone resonance assignment and solution secondary structure determination of human NSD1 and NSD2

  • Nader Amin
  • Daniel Nietlispach
  • Seema Qamar
  • Joe Coyle
  • Elisabetta Chiarparin
  • Glyn WilliamsEmail author


Proteins of the NSD family are histone-methyl transferases with critical functions in the regulation of chromatin structure and function. NSD1 and NSD2 are homologous proteins that function as epigenetic regulators of transcription through their abilities to catalyse histone methylation. Misregulation of NSD1 and NSD2 expression or mutations in their genes are linked to a number of human diseases such as Sotos syndrome, and cancers including acute myeloid leukemia, multiple myeloma, and lung cancer. The catalytic domain of both proteins contains a conserved SET domain which is involved in histone methylation. Here we report the backbone resonance assignments and secondary structure information of the catalytic domains of human NSD1 and NSD2.


Nuclear receptor-binding SET domain NSD1 NSD2 MMSET WHSC1 NSD family Histone-methyl transferase NMR resonance assignments NMR stability screen 


  1. Berdasco M, Ropero S, Setien F, Fraga MF, Lapunzina P, Losson R, Alaminos M, Cheung N, Rahman N, Esteller M (2009) Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 inhuman neuroblastoma and glioma. Proc Natl Acad Sci USA 106(51):21830–21835ADSCrossRefGoogle Scholar
  2. Douglas J, Hanks S, Temple IK, Davies S, Murray A, Upadhyaya M, Tomkins S, Hughes HE, Cole TR, Rahman N (2003) NSD1 mutations are the major cause of Sotos syndrome and occur in some cases of Weaver syndrome but are rare in other overgrowth phenotypes. Am J Hum Genet 72(1):132–143CrossRefGoogle Scholar
  3. Hafsa NE, Wishart DS (2014) CSI 2.0: a significantly improved version of the chemical shift index. J Biomol NMR 60:131–146Google Scholar
  4. Huang N, Vom Baur E, Garnier JM, Lerouge T, Vonesch JL, Lutz Y, Chambon P, Losson R (1998) Two distinct nuclear receptor interaction domains in NSD1, a novel SET protein that exhibits characteristics of both corepressors and coactivators. EMBO J 17(12):3398–3412CrossRefGoogle Scholar
  5. Jaju RJ, Fidler C, Haas OA, Strickson AJ, Watkins F, Clark K, Cross NC, Cheng JF, Aplan PD, Kearney L, Boultwood J, Wainscoat JS (2001) A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood acute myeloid leukemia. Blood 98(4):1264–1267CrossRefGoogle Scholar
  6. Kabsch W, Sander C (1983) Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22(12):2577–2637Google Scholar
  7. Keats JJ, Reiman T, Maxwell CA, Taylor BJ, Larratt LM, Mant MJ, Belch AR, Pilarski LM (2003) In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression. Blood 101(4):1520–1529CrossRefGoogle Scholar
  8. Kurotaki N, Harada N, Yoshiura K, Sugano S, Niikawa N, Matsumoto N (2001) Molecular characterization of NSD1, a human homologue of the mouse Nsd1 gene. Gene 279(2):197–204CrossRefGoogle Scholar
  9. La Starza R, Gorello P, Rosati R, Riezzo A, Veronese A, Ferrazzi E, Martelli MF, Negrini M, Mecucci C (2004) Cryptic insertion producing two NUP98/NSD1 chimeric transcripts in adult refractory anemia with an excess of blasts. Genes Chromosom Cancer 41(4):395–399CrossRefGoogle Scholar
  10. Li Y, Trojer P, Xu CF, Cheung P, Kuo A, Drury WJ III, Qiao Q, Neubert TA, Xu RM, Gozani O, Reinberg D (2009) The target of the NSD family of histone lysine methyltransferases depends on the nature of the substrate. J Biol Chem 284(49):34283–34295CrossRefGoogle Scholar
  11. Lu T, Jackson MW, Wang B, Yang M, Chance MR, Miyagi M, Gudkov AV, Stark GR (2010) Regulation of NF-kappaB by NSD1/FBXL11-dependent reversible lysine methylation of p65. Proc Natl Acad Sci USA. 107(1):46–51ADSCrossRefGoogle Scholar
  12. Needleman SB, Wunsch CD (1970) A general method applicable to the search for similarities in the amino acid sequence of two proteins. J Mol Biol 48(3):443–453CrossRefGoogle Scholar
  13. Pei H, Zhang L, Luo K, Qin Y, Chesi M, Fei F, Bergsagel PL, Wang L, You Z, Lou Z (2011) MMSET regulates histone H4K20 methylation and 53BP1 accumulation at DNA damage sites. Nature 470(7332):124–128ADSCrossRefGoogle Scholar
  14. Qiao Q, Li Y, Chen Z, Wang M, Reinberg D, Xu RM (2011) The structure of NSD1 reveals an autoregulatory mechanism underlying histone H3K36 methylation. J Biol Chem 286(10):8361–8368CrossRefGoogle Scholar
  15. Rayasam GV, Wendling O, Angrand PO, Mark M, Niederreither K, Song L, Lerouge T, Hager GL, Chambon P, Losson R (2003) NSD1 is essential for early post- implantation development and has a catalytically active SET domain. EMBO J 22(12):3153–3163CrossRefGoogle Scholar
  16. Sattler M, Schleucher J, Griesinger C (1999) Heteronuclear multidimensional NMR experiments for the structure determination of proteins in solution employing pulsed field gradients. Prog NMR Spectrosc 34(2):93–158CrossRefGoogle Scholar
  17. Tonon G, Wong K-K, Maulik G, Brennan C, Feng B, Zhang Y, Khatry DB, Protopopov A, You MJ, Aguirre AJ, Martin ES, Yang Z, Ji H, Chin L, de Pinho RA (2005) High-resolution genetic profiles of lung cancer. Proc Natl Acad Sci 102(27):9625–9630Google Scholar
  18. Varier RA, Timmers HT (2011) Histone lysine methylation and demethylation pathways in cancer. Biochim Biophys Acta, Rev Cancer 1815(1):75–89CrossRefGoogle Scholar
  19. Vranken WF, Boucher W, Stevens TJ, Fogh RH, Pajon A, Llinas M, Ulrich EL, Markley JL, Ionides J, Laue ED (2005) The CCPN Data Model for NMR Spectroscopy: development of a software pipeline. Proteins 59:687–696Google Scholar
  20. Wang GG, Cai L, Pasillas MP, Kamps MP (2007) NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis. Nat Cell Biol 9(7):804–812CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2016

Authors and Affiliations

  • Nader Amin
    • 1
    • 4
  • Daniel Nietlispach
    • 2
  • Seema Qamar
    • 3
  • Joe Coyle
    • 1
  • Elisabetta Chiarparin
    • 1
    • 5
  • Glyn Williams
    • 1
    Email author
  1. 1.Astex PharmaceuticalsCambridgeUK
  2. 2.Department of BiochemistryUniversity of CambridgeCambridgeUK
  3. 3.Cambridge Institute for Medical ResearchUniversity of CambridgeCambridgeUK
  4. 4.Nuffield Department of Population HealthUniversity of OxfordOxfordUK
  5. 5.AstraZenecaCambridgeUK

Personalised recommendations